Leading the way to safer medication
 Crosscheck  Recommender

Betahistine

Also known as: Betahistine hydrochloride

Brand names: SERC

Therapeutic Indications

Betahistine is indicated for:

Ménière's syndrome

Irrespective of gender only Adults (18 years old or older)

Vertigo, tinnitus and hearing loss associated with Ménière’s syndrome.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 24-48 mg in 3 divided doses daily

Contraindications

Active ingredient Betahistine is contraindicated in the following cases:

Pheochromocytoma

No gender/age discrimination